Evidence map›Paper›PMID 39374469›Full record

ArticleNeurology2024

Seizures and Epilepsy in Association With Neurocysticercosis: A Nosologic Proposal.

Gagandeep Singh, Hector H Garcia, Oscar H Del Brutto, Christina Coyle, Josemir W Sander

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gagandeep SinghFrom the Department of Neurology (G.S.), Dayanand Medical College & Hospital, Ludhiana, India; Center for Global Health and School of Sciences (H.H.G.), Universidad Peruana Cayetano Heredia; Cysticercosis Unit (H.H.G.), Instituto Nacional de Ciencaia Neurologicas, Lima, Peru; School of Medicine and Research Center (O.H.D.B.), Universidad Espiritu Santo-Ecuador, Samborondón; Albert Einstein College of Medicine (C.C.), Bronx, NY; Department of Clinical & Experimental Epilepsy (J.W.S.), UCL Queen Square Institute of Neurology, London; and Chalfont Centre for Epilepsy (J.W.S.), Chalfont St Peter, United Kingdom.ORCID 0000-0001-6661-3553
Hector H GarciaFrom the Department of Neurology (G.S.), Dayanand Medical College & Hospital, Ludhiana, India; Center for Global Health and School of Sciences (H.H.G.), Universidad Peruana Cayetano Heredia; Cysticercosis Unit (H.H.G.), Instituto Nacional de Ciencaia Neurologicas, Lima, Peru; School of Medicine and Research Center (O.H.D.B.), Universidad Espiritu Santo-Ecuador, Samborondón; Albert Einstein College of Medicine (C.C.), Bronx, NY; Department of Clinical & Experimental Epilepsy (J.W.S.), UCL Queen Square Institute of Neurology, London; and Chalfont Centre for Epilepsy (J.W.S.), Chalfont St Peter, United Kingdom.
Oscar H Del BruttoFrom the Department of Neurology (G.S.), Dayanand Medical College & Hospital, Ludhiana, India; Center for Global Health and School of Sciences (H.H.G.), Universidad Peruana Cayetano Heredia; Cysticercosis Unit (H.H.G.), Instituto Nacional de Ciencaia Neurologicas, Lima, Peru; School of Medicine and Research Center (O.H.D.B.), Universidad Espiritu Santo-Ecuador, Samborondón; Albert Einstein College of Medicine (C.C.), Bronx, NY; Department of Clinical & Experimental Epilepsy (J.W.S.), UCL Queen Square Institute of Neurology, London; and Chalfont Centre for Epilepsy (J.W.S.), Chalfont St Peter, United Kingdom.ORCID 0000-0003-1917-8805
Christina CoyleFrom the Department of Neurology (G.S.), Dayanand Medical College & Hospital, Ludhiana, India; Center for Global Health and School of Sciences (H.H.G.), Universidad Peruana Cayetano Heredia; Cysticercosis Unit (H.H.G.), Instituto Nacional de Ciencaia Neurologicas, Lima, Peru; School of Medicine and Research Center (O.H.D.B.), Universidad Espiritu Santo-Ecuador, Samborondón; Albert Einstein College of Medicine (C.C.), Bronx, NY; Department of Clinical & Experimental Epilepsy (J.W.S.), UCL Queen Square Institute of Neurology, London; and Chalfont Centre for Epilepsy (J.W.S.), Chalfont St Peter, United Kingdom.
Josemir W SanderFrom the Department of Neurology (G.S.), Dayanand Medical College & Hospital, Ludhiana, India; Center for Global Health and School of Sciences (H.H.G.), Universidad Peruana Cayetano Heredia; Cysticercosis Unit (H.H.G.), Instituto Nacional de Ciencaia Neurologicas, Lima, Peru; School of Medicine and Research Center (O.H.D.B.), Universidad Espiritu Santo-Ecuador, Samborondón; Albert Einstein College of Medicine (C.C.), Bronx, NY; Department of Clinical & Experimental Epilepsy (J.W.S.), UCL Queen Square Institute of Neurology, London; and Chalfont Centre for Epilepsy (J.W.S.), Chalfont St Peter, United Kingdom.ORCID 0000-0001-6041-9661

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurocysticercosis is one of the main risk factors of seizures and epilepsy in many regions of the world, which are

Indexed as

EpilepsyNeurocysticercosisSeizuresAnimalsHumansTaenia solium

Identifiers

PMID39374469
PMCPMC11460340

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.